This site has been optimized to work with modern browsers and does not fully support your version of Internet Explorer.

Identifying uncontrolled asthma in primary care



Collaboration between the NHS Accelerated Access Collaborative, AstraZeneca and the Oxford AHSN has resulted in the development of SPECTRA, a suite of clinical audit tools to support the identification of uncontrolled asthma patients in primary care. Find out more about SPECTRA in this webinar.

Further information and booking details

Event Types: Clinical Innovation Adoption